secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001193125-22-277914
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health issues $1.8B of notes in three tranches at 5.35%-6.10%
----------------------------------------------------------------------

- $400M 5.350% notes due 2025, $650M 5.500% notes due 2032, $750M 6.100% notes due 2052.
- Net proceeds of approx. $1.7802B after underwriting discounts and offering expenses.
- Intends to use proceeds for working capital, acquisitions, debt repayment, and share repurchases.
- Underwriters: BofA Securities and Deutsche Bank Securities as representatives.
- Notes registered under Form S-3; interest semi-annual beginning April 15, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522277914/0001193125-22-277914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522277914/d416104d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-277914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer